Business Context and Reporting Period
This Form 8-K filing by McKesson Corporation covers the date of March 31, 2012. The report addresses a change in the Company's executive leadership structure.
Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report is limited to corporate governance updates and does not contain financial performance data.
Material Changes
Effective March 31, 2012, Marc E. Owen resigned from his position as Executive Vice President, Corporate Strategy and Business Development. Mr. Owen was previously identified as a named executive officer in the Company's 2011 definitive proxy statement.
Outlook and Management Commentary
While Mr. Owen is no longer serving as an executive officer, he will continue to serve the Company as President of McKesson Specialty Health, a role he assumed on January 31, 2012. The filing contains no additional guidance, risk factors, or unusual items.
Key Facts for Investor Verification
- Marc E. Owen's resignation as Executive Vice President, Corporate Strategy and Business Development was effective March 31, 2012.
- Mr. Owen remains with the Company as President of McKesson Specialty Health.
- No financial results or forward-looking guidance are included in this specific filing.